14th International Symposium on Hodgkin Lymphoma
Oct. 03.-05. 2026
Gürzenich, Cologne
Saturday 03.10.2026
Scientific Session
Satellite Symposium
Main Program
Workshop
Export calendar
08:30–11:00
Workshop 1
(Parallel Sessions)
Workshop on ctDNA in HL
Separate registration required- SvenBorchmann Cologne
- Maria CristinaPirosa Bellinzona
- StefanAlig München
- ChristianSteidl Vancouver
08:30–11:00
Scientific Session 1
(Parallel Sessions)
EHA-LYG/GHSG Joint Session: EHA Clinical Practice Guidelines in Lymphoid Malignancies - From Recommendations to Patient Care
- IgorAurer Zagreb
- Bastianvon Tresckow Essen
Large B-cell lymphomas
- SirpaLeppä Helsinki
Mantle cell lymphoma
- IgorAurer Zagreb
Follicular lymphoma
- MarcusHentrich München
HIV-related lymphomas
- FrancescoDamore Aarhus N
Peripheral T-cell lymphoma
- FrancescoDamore Aarhus N
New Therapeutic Concepts and Horizons in Lymphoma
- CatherineDiefenbach New York
08:30–11:00
Workshop 2
(Parallel Sessions)
Individualization of Radiation Therapy for Hodgkin Lymphoma
Separate registration required- JoachimYahalom New York
- Hans TheodorEich Münster
11:30–12:30
Satellite Symposium
Moving Targets: Rethinking Cellular Therapy Delivery in Aggressive B-Cell Lymphomas
Opening and Framing
- Bastianvon Tresckow Essen
R/R DLBCL Treatment Landscape
- GillesSalles New York
Difficult-to-Treat Patients in R/R DLBCL
- IgorAurer Zagreb
CAR-T Delivery and Treatment Timing: Clinical Challenges and Opportunities
- Bastianvon Tresckow Essen
Future Directions in Cellular Therapy
- AnnaSureda Barcelona
Panel Discussion and Q&A
Personalized RTx: Focus on RTx Techniques and Late Effect Prediction Models
- DavidCutter Oxford
Just PD1-Inhibition? Early Insights from the GHSG INDIE Trial
- Paul J.Bröckelmann Cologne
Debate: Should Novel Agents Be Integrated Into the Frontline Treatment of Early Stage Low Risk HL Patients?
- GrahamCollins Oxford
- CatherineDiefenbach New York
Oral Abstract Presentations
Keynote Lecture: Changing treatment paradigms in B cell Lymphoma
- GillesSalles New York
Sunday 04.10.2026
Scientific Session
Satellite Symposium
Main Program
Workshop
Export calendar
08:00–09:15
Scientific Session 3
HL in Children and Adolescents
- ChristineMauz-Körholz Gießen
- JamieFlerlage Memphis
Treatment Evolution in Pediatric Hodgkin Lymphoma: From Research to Real-World Impact
- MaurizioMascarin Aviano
Precision Medicine in Pediatric HL / Harmonized Pediatric HL Protocol in South Africa
- JenniferGeel Johannesburg
Oral Abstract Presentations
08:00–10:00
Workshop 3
Closed Workshop on Grassroot Initiative in Classic Hodgkin Lymphoma
Separate registration required- RanjanaAdvani Stanford
- Peter OmondiOyiro
- PeterBorchmann Cologne
09:30–10:30
Satellite Symposium
New concepts for the treatment of B-cell lymphomas
- Bastianvon Tresckow Essen
DLBCL – The current and future role of ADCs in the context of T-cell engaging therapies
- BjörnChapuy Berlin
cHL – Treatment strategies for PD-1 inhibition in the relapsed / refractory setting
- Bastianvon Tresckow Essen
10:45–12:00
Scientific Session 4
Translating ctDNA into clinical routine
- SvenBorchmann Cologne
- MargaretShipp Boston
Circulating Tumor DNA: New insights from the SWOG S1826 study.
- MargaretShipp Boston
Circulating Tumor DNA Analysis for Classification and MRD Assessment – Experience of the German Hodgkin Study Group
- SvenBorchmann Cologne
Workshop Report
- ChristianSteidl Vancouver
Oral Abstract Presentations
The Biology of HRS Cells
- RalfKüppers Essen
Novel Insights Into the Microenvironment of Hodgkin Lymphoma
- TomohiroAoki Toronto
Oral Abstract Presentations
13:45–15:15
Satellite Symposium
From Evidence to Experience: How Long-Term and Real-World Data for ADCETRIS® (brentuximab vedotin) May Inform Frontline Practice in Advanced Hodgkin Lymphoma
- Bastianvon Tresckow Essen
Enhancing Frontline Management in Advanced HL with BrECADD
- OtavioBaiocchi São Paulo
Advancing HL Control and Fertility Preservation with BrECADD
- EldadDann Haifa
Optimizing Care in High-Risk HL with A+AVD
- CathyBurton Leeds
Evaluating Late Effects of Contemporary Treatments - Competing Risks & Novel Approaches
- CarolineDietrich Stockholm
Uncertainties with Anti-PD1 & irAE in the First-Line Setting
- Paul J.Bröckelmann Cologne
In Conversation with GHSG Patient Representatives: Building a Bridge Between Cancer Treatment and Everyday Life – Challenges After Lymphoma
Oral Abstract Presentations
17:00–18:30
Scientific Session 7
Advanced Stages
- MarkHertzberg Randwick
- GrahamCollins Oxford
- PhilippeArmand Boston
Unmet Needs and Future Perspectives with BrECADD: Improving Outcomes of HD21
- JustinFerdinandus Cologne
Unmet Needs and Future Perspectives with Nivo-AVD: Unanswered Questions from SWOG S1826
- AlexHerrera Duarte
Oral Abstract Presentations
Monday 05.10.2026
Scientific Session
Satellite Symposium
Main Program
Workshop
Export calendar
08:00–09:15
Scientific Session 8
Special Cases & Situations
- JoséeZijlstra Amsterdam
- Paul J.Bröckelmann Cologne
HL in Pregnancy
- Anne-SophieRobertz Köln
Critical Organ Failure at Presentation
- HishanTharmaseelan Cologne
Anti-PD1 Tx in Pre-Existing Autoimmune Disease
Workshop Report “Grassroot Initiative in Classic Hodgkin Lymphoma”
- RanjanaAdvani Stanford
- Peter OmondiOyiro
Clinical Implications of Growth Patterns
- DennisEichenauer Cologne
Treatment Strategies
- JamieFlerlage Memphis
Oral Abstract Presentations
10:45–12:15
Scientific Session 10
Relapsed & Refractory HL
- Craig H.Moskowitz New York
- AnnaSureda Barcelona
2L Treatment of HL in Era of Novel Agents
- AlisonMoskowitz New York
Revisiting the Role of Stem Cell Transplantation in rrHL
- Bastianvon Tresckow Essen
Unmet Needs and Novel Treatment Approaches in >3L
- MartinHutchings Copenhagen
Oral Abstract Presentations
Best of ISHL14
- RanjanaAdvani Stanford
Farewell
- PeterBorchmann Cologne
- Ranjana Advani
- Stefan Alig
- Tomohiro Aoki
- Philippe Armand
- Igor Aurer
- Otavio Baiocchi
- Karolin Behringer
- Peter Borchmann
- Sven Borchmann
- Paul J. Bröckelmann
- Cathy Burton
- Max Büttner
- Björn Chapuy
- Graham Collins
- David Cutter
- Francesco Damore
- Eldad Dann
- Catherine Diefenbach
- Caroline Dietrich
- Hans Theodor Eich
- Dennis Eichenauer
- Justin Ferdinandus
- Jamie Flerlage
- Alexander Fosså
- Jennifer Geel
- Marcus Hentrich
- Alex Herrera
- Mark Hertzberg
- Richard Hoppe
- Martin Hutchings
- Wolfram Klapper
- Ralf Küppers
- Sirpa Leppä
- Maurizio Mascarin
- Christine Mauz-Körholz
- Alison Moskowitz
- Craig H. Moskowitz
- Peter Omondi Oyiro
- GHSG patient representatives
- Maria Cristina Pirosa
- Anne-Sophie Robertz
- Gilles Salles
- Margaret Shipp
- Christian Steidl
- Anna Sureda
- Hishan Tharmaseelan
-
Bastian
von Tresckow
Bastian.vonTresckow@uk-essen.de
- 03.10., 08:30–11:00, EHA-LYG/GHSG Joint Session: EHA Clinical Practice Guidelines in Lymphoid Malignancies - From Recommendations to Patient Care (Chair)
- 04.10., 09:30–10:30, New concepts for the treatment of B-cell lymphomas (Chair, Speaker)
- 04.10., 13:45–15:15, From Evidence to Experience: How Long-Term and Real-World Data for ADCETRIS® (brentuximab vedotin) May Inform Frontline Practice in Advanced Hodgkin Lymphoma (Chair)
- 03.10., 11:30–12:30, Moving Targets: Rethinking Cellular Therapy Delivery in Aggressive B-Cell Lymphomas (Speaker)
- 05.10., 10:45–12:15, Relapsed & Refractory HL (Speaker)
- Joachim Yahalom
- Josée Zijlstra
Scientific Committee
